{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=0.9%25+Sodium+Chloride+%28NaCl%29&page=68", "query": { "intervention": "0.9% Sodium Chloride (NaCl)", "page": 68 }, "page_size": 10 }, "pagination": { "page": 68, "page_size": 10, "total_count": 1988, "total_pages": 199, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=0.9%25+Sodium+Chloride+%28NaCl%29&page=69&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=0.9%25+Sodium+Chloride+%28NaCl%29&page=67&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-30T20:49:27.037Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02668952", "title": "Fluid Chloride and AKI in Cardiopulmonary Bypass", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acute Kidney Injury" ], "interventions": [ { "name": "0.9% Normal Saline (0.9% Sodium Chloride) injection", "type": "DRUG" }, { "name": "Isolyte S injection", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of New Mexico", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2016-01", "completion_date": "2018-02", "has_results": true, "last_update_posted_date": "2018-05-14", "last_synced_at": "2026-10-30T20:49:27.037Z", "location_count": 1, "location_summary": "Albuquerque, New Mexico", "locations": [ { "city": "Albuquerque", "state": "New Mexico" } ], "official_url": "https://clinicaltrials.gov/study/NCT02668952" }, { "nct_id": "NCT04242368", "title": "Hypertonic Versus Isotonic Saline Irrigations for Chronic Rhinosinusitis", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Chronic Rhinosinusitis (Diagnosis)" ], "interventions": [ { "name": "Isotonic saline", "type": "DRUG" }, { "name": "Hypertonic Nasal Wash", "type": "DRUG" }, { "name": "Fluticasone Propionate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2020-07-01", "completion_date": "2021-07-01", "has_results": false, "last_update_posted_date": "2021-03-18", "last_synced_at": "2026-10-30T20:49:27.037Z", "location_count": 1, "location_summary": "Stanford, California", "locations": [ { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04242368" }, { "nct_id": "NCT00752050", "title": "Safety and Efficacy Study of Repeat Treatment With PurTox® Botulinum Toxin Type A for Frown Lines Between the Eyebrows", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Glabellar Rhytides", "Frown Lines Between the Eyebrows" ], "interventions": [ { "name": "Mentor Purified Toxin Botulinum Toxin Type A", "type": "DRUG" }, { "name": "Preservative-free Saline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mentor Worldwide, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 699, "start_date": "2007-11", "completion_date": "2009-03", "has_results": false, "last_update_posted_date": "2011-09-12", "last_synced_at": "2026-10-30T20:49:27.037Z", "location_count": 1, "location_summary": "Santa Barbara, California", "locations": [ { "city": "Santa Barbara", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00752050" }, { "nct_id": "NCT00349778", "title": "High-Dose Sequential Therapy and Single Autologous Transplantation for Multiple Myeloma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Multiple Myeloma" ], "interventions": [ { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Etoposide", "type": "DRUG" }, { "name": "Melphalan", "type": "DRUG" }, { "name": "Carmustine", "type": "DRUG" }, { "name": "Filgrastim", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 102, "start_date": "2006-08", "completion_date": "2010-04", "has_results": true, "last_update_posted_date": "2017-12-12", "last_synced_at": "2026-10-30T20:49:27.037Z", "location_count": 1, "location_summary": "Stanford, California", "locations": [ { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00349778" }, { "nct_id": "NCT01410227", "title": "Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Von Willebrand Disease" ], "interventions": [ { "name": "Recombinant von Willebrand factor (rVWF)", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Recombinant factor VIIII (rFVIII)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Baxalta now part of Shire", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 49, "start_date": "2011-11-01", "completion_date": "2014-02-01", "has_results": true, "last_update_posted_date": "2021-05-19", "last_synced_at": "2026-10-30T20:49:27.037Z", "location_count": 10, "location_summary": "Sacramento, California • Miami, Florida • Peoria, Illinois + 7 more", "locations": [ { "city": "Sacramento", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Peoria", "state": "Illinois" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Newark", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT01410227" }, { "nct_id": "NCT05469802", "title": "A Study of Purified Inactivated Zika Virus Vaccine (PIZV) in Healthy Adults", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "Purified Inactivated Zika Virus Vaccine (PIZV)", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "49 Years", "sex": "ALL", "summary": "18 Years to 49 Years" }, "enrollment_count": 0, "start_date": "2024-01-02", "completion_date": "2024-07-05", "has_results": false, "last_update_posted_date": "2024-03-13", "last_synced_at": "2026-10-30T20:49:27.037Z", "location_count": 5, "location_summary": "Oakland Park, Florida • Meridian, Idaho • Wichita, Kansas + 2 more", "locations": [ { "city": "Oakland Park", "state": "Florida" }, { "city": "Meridian", "state": "Idaho" }, { "city": "Wichita", "state": "Kansas" }, { "city": "Lexington", "state": "Kentucky" }, { "city": "Kansas City", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT05469802" }, { "nct_id": "NCT03592277", "title": "Vitamin C & Thiamine to Treat Sepsis and Septic Shock", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Sepsis", "Septic Shock" ], "interventions": [ { "name": "Vitamin C", "type": "DRUG" }, { "name": "Vitamin B1", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Trinity Health Of New England", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 120, "start_date": "2018-09-14", "completion_date": "2021-02-22", "has_results": true, "last_update_posted_date": "2022-09-28", "last_synced_at": "2026-10-30T20:49:27.037Z", "location_count": 1, "location_summary": "Hartford, Connecticut", "locations": [ { "city": "Hartford", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT03592277" }, { "nct_id": "NCT00516958", "title": "Pilot Study of the Safety and Clinical Efficacy of Topical Dermacyn™ Wound Care to Treat Mild Diabetic Foot Infections", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Foot Ulcer, Diabetic" ], "interventions": [ { "name": "Topical Dermacyn", "type": "DRUG" }, { "name": "Topical Dermacyn and Levofloxacin", "type": "DRUG" }, { "name": "Topical Saline and Levofloxacin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Oculus Innovative Sciences, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 65, "start_date": "2007-05", "completion_date": "2007-12", "has_results": false, "last_update_posted_date": "2008-01-14", "last_synced_at": "2026-10-30T20:49:27.037Z", "location_count": 16, "location_summary": "Tucson, Arizona • La Jolla, California • Los Angeles, California + 13 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Santa Rosa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00516958" }, { "nct_id": "NCT04305743", "title": "Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Urinary Bladder, Overactive", "Incontinence, Urge", "Incontinence, Urinary", "Urinary Urge Incontinence", "Urinary Frequency More Than Once at Night", "Nocturia" ], "interventions": [ { "name": "OnabotulinumtoxinA 100 UNT", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of South Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 60, "start_date": "2019-10-09", "completion_date": "2021-06-01", "has_results": false, "last_update_posted_date": "2020-11-05", "last_synced_at": "2026-10-30T20:49:27.037Z", "location_count": 2, "location_summary": "Washington D.C., District of Columbia • Tampa, Florida", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04305743" }, { "nct_id": "NCT01810276", "title": "Safety of Platelet Transfusion in Patients on Antiplatelet Therapy With Traumatic Head Injury", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Traumatic Head Injury", "Intracranial Hemmorhage", "Anti-platelet Therapy" ], "interventions": [ { "name": "Saline", "type": "OTHER" }, { "name": "Platelets", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Christiana Care Health Services", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 40, "start_date": "2012-06", "completion_date": "2013-04", "has_results": false, "last_update_posted_date": "2017-04-18", "last_synced_at": "2026-10-30T20:49:27.037Z", "location_count": 1, "location_summary": "Newark, Delaware", "locations": [ { "city": "Newark", "state": "Delaware" } ], "official_url": "https://clinicaltrials.gov/study/NCT01810276" } ] }